Novartis has been at the forefront of advances in how blood cancers and serious blood disorders are treated, helping patients live their best lives.

Combination of two compounds shows promise in the lab

Building on more than two decades of chronic myeloid leukemia research, the R&D teams at Novartis pursued an investigational treatment unlike any other.

An antibody that boosts muscle mass could mean independence for the frail and elderly. Learn how Novartis research aims to improve healthy aging.

Immunotherapy for cancer is on the brink of breakthroughs. Learn how NIBR have high expectations for this medical science.

Chinweike Ukomadu thinks that notions about clinicians turning their backs on patients when transitioning to industry are outdated.

Lisa, a patient living with CML, shares her experience and discusses the importance of speaking up about unmet needs in your disease.

The disease hobbles families and economies.